2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Evidence-based Complementary and Alternative Medicine EVID-BASED COMPL ALT (此期刊未被最新的JCR期刊引证报告收录) LetPub评分 5.8
70人评分
我要评分
声誉 6.1 影响力 4.7 速度 8.6 | |||||||||||||||||
期刊ISSN | 1741-427X | 微信扫码收藏此期刊 | ||||||||||||||||
E-ISSN | 1741-4288 | |||||||||||||||||
2022-2023最新影响因子 (数据来源于搜索引擎) | 0 点击查看影响因子趋势图 | |||||||||||||||||
实时影响因子 | 截止2023年12月27日:1.581 | |||||||||||||||||
2022-2023自引率 | N.A.点击查看自引率趋势图 | |||||||||||||||||
五年影响因子 | 0 | |||||||||||||||||
h-index | 72 | |||||||||||||||||
CiteScore |
| |||||||||||||||||
期刊简介 | Evidence-Based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research in this new, yet ancient world of complementary and alternative medicine. The journal seeks to apply scientific rigor to the study of complementary and alternative medicine (CAM) modalities, particularly traditional Asian healing systems. eCAM emphasizes health outcome, while documenting biological mechanisms of action. The journal is devoted to the advancement of science in the field of basic research, clinical studies, methodology or scientific theory in diverse areas of Biomedical Sciences. The journal does not consider articles on homeopathy. | |||||||||||||||||
期刊官方网站 | https://www.hindawi.com/journals/ecam | |||||||||||||||||
期刊投稿网址 | http://mts.hindawi.com/login/ | |||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Evidence-based Complementary and Alternative Medicine的语言要求,还能让Evidence-based Complementary and Alternative Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Evidence-based Complementary and Alternative Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( USD2400; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:alternative medicine、complementary therapies 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review | |||||||||||||||||
通讯方式 | OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP | |||||||||||||||||
出版商 | Hindawi Publishing Corporation | |||||||||||||||||
涉及的研究方向 | 医学-全科医学与补充医学 | |||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||
出版语言 | English | |||||||||||||||||
出版周期 | Quarterly | |||||||||||||||||
出版年份 | 2004 | |||||||||||||||||
年文章数 | 1405点击查看年文章数趋势图 | |||||||||||||||||
Gold OA文章占比 | 98.70% | |||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 83.06% | |||||||||||||||||
WOS期刊SCI分区 ( 2022-2023年最新版) | WOS分区等级:0区 暂无按学科分区信息 | |||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 预警提示:2023年3月20日剔除出SCIE目录 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||
中科院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中科院SCI期刊分区趋势图 (没有被最新的JCR升级版收录,仅供参考) | |||||||||||||||||
中科院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||
中科院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||
SCI期刊收录coverage | 预警提示:2023年3月20日剔除出SCIE目录 Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1741-427X%5BISSN%5D | |||||||||||||||||
平均审稿速度 | 网友分享经验: 平均2.2月 | |||||||||||||||||
平均录用比例 | 网友分享经验: 约50% | |||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Evidence-based Complementary and Alternative Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||
期刊常用信息链接 |
|
中国学者近期发表的论文 | |
1. | Protective Effects of Clinacanthus nutans (Burm.f.) Lindau Aqueous Extract on HBV Mouse Model by Modulating Gut Microbiota and Liver Metabolomics Author: Zhang, Rui; Lu, Zhe; Xu, Yachen; Peng, Qian; Xiao, Man; Sang, Shenggang Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/5625222 PubMed DOI |
2. | Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition Author: Tang, Ling; Yu, Xiao; Zou, Lu; Li, Shaobin; Cheng, Yanqi; Wu, Yuqin; Xing, Lianjun; Fang, Hong Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/5642713 PubMed DOI |
3. | Integrated Network Pharmacology and Gut Microbiota Analysis to Explore the Mechanism of Sijunzi Decoction Involved in Alleviating Airway Inflammation in a Mouse Model of Asthma Author: Jia, Wenqing; Xu, Chengling; Zhao, Tong; Fan, Qiuyang; Qiao, Bo; Wu, Yueying; Yuan, Jiali; Chen, Jing Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/1130893 PubMed DOI |
4. | Network Pharmacology Approach to Investigate the Mechanism of Danggui-Shaoyao-San against Diabetic Kidney Disease Author: Chen, Yulian; Song, Xiaodan; Luo, Yunxia; Li, Guandong; Luo, Yueming; Wang, Ziyan; He, Riming; Lu, Jiandong; Xiong, Guoliang; Cheng, Hong; Li, Huilin; Yang, Shudong Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9208017 PubMed DOI |
5. | beta-Sitosterol Suppresses LPS-Induced Cytokine Production in Human Umbilical Vein Endothelial Cells via MAPKs and NF-kappa B Signaling Pathway Author: Bi, Yiming; Liang, Hongfeng; Han, Xin; Li, Kongzheng; Zhang, Wei; Lai, Yigui; Wang, Qiang; Jiang, Xuefeng; Zhao, Xiaoshan; Fan, Huijie Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9241090 PubMed DOI |
6. | Parthenolide Attenuates Sepsis-Induced Acute Kidney Injury in Rats by Reducing Inflammation Author: Shou, Di-Wen; Li, Yi-Rong; Xu, Xiu-Juan; Dai, Mu-Hua; Zhang, Wei; Yang, Xue; Tu, Yue-Xing Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/8759766 PubMed DOI |
7. | Effects of a Macroporous Resin Extract of Dendrobium officinale Leaves in Rats with Hyperuricemia Induced by Anthropomorphic Unhealthy Lifestyle Author: Li, Lin-Zi; Wang, Xi-Ming; Feng, Xiao-Jie; Liu, Kun; Li, Bo; Zhu, Li-Jie; Xu, Wan-Feng; Zheng, Xiang; Dong, Ying-Jie; He, Xing-Lishang; Guan, Hao-Ru; Ding, Yan-Yan; Wu, Han-Song; Zhou, Chuan-Jie; Ye, Sen-Yu; Zhang, Bei-Bei; Lv, Gui-Yuan; Chen, Su-Hong Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9990843 PubMed DOI |
8. | Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of Hedyotis diffusa Willd in Liver Cancer Author: Wu, Hongyan; Zhang, Lihu; Wang, Chuntao; Li, Fang; Qi, Liang; Xiao, Linxia; Zhang, Mingguang; Zhang, Hu; Zhang, Guozhe; Qin, Yiyu Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/1416841 PubMed DOI |
9. | A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification Author: Hu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei; Lin, Lizhu Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/3436814 PubMed DOI |
10. | Rhinacanthin C Ameliorates Insulin Resistance and Lipid Accumulation in NAFLD Mice via the AMPK/SIRT1 and SREBP-1c/FAS/ACC Signaling Pathways Author: Gong, Zhiqiang; Han, Sha; Li, Chenlin; Meng, Tianxiu; Huo, Yu; Liu, Xianfu; Huang, Yanhong; Yang, Lifang Journal: EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/6603522 PubMed DOI |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共1879条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451